Celularity Inc. Investment Income, Interest
Celularity Inc. (CELU) reported Investment Income, Interest of $9.18 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-19.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2021-08-19
- Celularity Inc. investment income, interest for the quarter ending 2021-06-30 was $9.18K, a 98.16% decline year-over-year.
- Celularity Inc. investment income, interest for the quarter ending 2021-03-31 was $27.88K, a 97.49% decline year-over-year.
- Celularity Inc. investment income, interest for the quarter ending 2020-12-31 was $71.29K, a 94.91% decline year-over-year.
- Celularity Inc. investment income, interest for the quarter ending 2020-09-30 was $100.73K, a 94.00% decline year-over-year.
- Celularity Inc. investment income, interest for fiscal 2020 was $1.78M, a 52.60% decline from fiscal 2019.
- Celularity Inc. investment income, interest for fiscal 2019 was $3.75M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2021-06-30 | $9.18K 10-Q · filed 2021-08-19 | $37.06K 10-Q · filed 2021-08-19 | $108.35K derived: sum of 3 quarters · filed 2021-08-19 | $209.08K derived: sum of 4 quarters · filed 2021-08-19 |
| 2021-03-31 | $27.88K 10-Q · filed 2021-05-24 | $99.17K derived: sum of 2 quarters · filed 2021-05-24 | $199.90K derived: sum of 3 quarters · filed 2021-05-24 | $697.88K derived: sum of 4 quarters · filed 2021-08-19 |
| 2020-12-31 | $71.29K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $172.02K derived: sum of 2 quarters · filed 2021-05-24 | $670.00K derived: sum of 3 quarters · filed 2021-08-19 | $1.78M 10-K/A · filed 2021-05-24 |
| 2020-09-30 | $100.73K 10-Q · filed 2020-11-16 | $598.70K derived: sum of 2 quarters · filed 2021-08-19 | $1.71M 10-Q · filed 2020-11-16 | $3.11M derived: sum of 4 quarters · filed 2021-08-19 |
| 2020-06-30 | $497.98K 10-Q · filed 2021-08-19 | $1.61M 10-Q · filed 2021-08-19 | $3.01M derived: sum of 3 quarters · filed 2021-08-19 | $4.69M derived: sum of 4 quarters · filed 2021-08-19 |
| 2020-03-31 | $1.11M 10-Q · filed 2021-05-24 | $2.51M derived: sum of 2 quarters · filed 2021-05-24 | $4.19M derived: sum of 3 quarters · filed 2021-05-24 | $4.86M derived: sum of 4 quarters · filed 2021-05-24 |
| 2019-12-31 | $1.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $3.08M derived: sum of 2 quarters · filed 2021-05-24 | $3.75M derived: sum of 3 quarters · filed 2021-05-24 | $3.75M 10-K/A · filed 2021-05-24 |
| 2019-09-30 | $1.68M 10-Q · filed 2020-11-16 | $2.35M derived: sum of 2 quarters · filed 2020-11-16 | $2.35M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $671.99K 10-Q · filed 2020-08-13 | $671.99K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |